Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
Piper Sandler maintains Vertex stock Overweight with $533 target
Piper Sandler expressed continued confidence in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), maintaining an Overweight ...
The Motley Fool25d
Is Vertex Pharmaceuticals Stock a Buy in 2025?
Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...
ETF Daily News7d
Empowered Funds LLC Purchases New Position in Vertex, Inc. (NASDAQ:VERX)
FMR LLC lifted its position in Vertex by 2.5% in the third quarter. FMR LLC now owns 2,287,774 shares of the company’s stock valued at $88,102,000 after acquiring an additional 54,985 shares ...
ETF Daily News1mon
Capital Investment Advisors LLC Cuts Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Vertex Pharmaceuticals Stock Up 3.1 % Shares of NASDAQ VRTX opened at $424.26 on Thursday. Vertex Pharmaceuticals Incorporated has a 52-week low of $377.85 and a 52-week high of $519.88. The ...